Form 8-K - Current report:
SEC Accession No. 0000950103-24-015809
Filing Date
2024-11-01
Accepted
2024-11-01 16:27:06
Documents
14
Period of Report
2024-11-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp220179_8k.htm   iXBRL 8-K 27809
2 EXHIBIT 10.1 dp220179_ex1001.htm EX-10.1 2067527
  Complete submission text file 0000950103-24-015809.txt   2706396

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE blco-20241101.xsd EX-101.SCH 3009
4 XBRL LABEL FILE blco-20241101_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE blco-20241101_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT dp220179_8k_htm.xml XML 3656
Mailing Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4
Business Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4 908-541-5456
Bausch & Lomb Corp (Filer) CIK: 0001860742 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41380 | Film No.: 241419419
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)